Does DACLATASVIR Cause Hepatic encephalopathy? 165 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Hepatic encephalopathy have been filed in association with DACLATASVIR. This represents 3.0% of all adverse event reports for DACLATASVIR.
165
Reports of Hepatic encephalopathy with DACLATASVIR
3.0%
of all DACLATASVIR reports
48
Deaths
101
Hospitalizations
How Dangerous Is Hepatic encephalopathy From DACLATASVIR?
Of the 165 reports, 48 (29.1%) resulted in death, 101 (61.2%) required hospitalization, and 11 (6.7%) were considered life-threatening.
Is Hepatic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLATASVIR. However, 165 reports have been filed with the FAERS database.
What Other Side Effects Does DACLATASVIR Cause?
Fatigue (510)
Hepatocellular carcinoma (419)
Headache (411)
Hepatitis c (400)
Drug ineffective (385)
Treatment failure (310)
Nausea (287)
Anaemia (251)
Ascites (205)
Off label use (199)
What Other Drugs Cause Hepatic encephalopathy?
ACETAMINOPHEN (562)
RIBAVIRIN (512)
LENVATINIB (502)
RIFAXIMIN (462)
SOFOSBUVIR (360)
BEVACIZUMAB (210)
LEDIPASVIR\SOFOSBUVIR (180)
ATEZOLIZUMAB (178)
SORAFENIB (169)
FUROSEMIDE (130)
Which DACLATASVIR Alternatives Have Lower Hepatic encephalopathy Risk?
DACLATASVIR vs DACLIZUMAB
DACLATASVIR vs DACOMITINIB
DACLATASVIR vs DACTINOMYCIN
DACLATASVIR vs DALBAVANCIN
DACLATASVIR vs DALFAMPRIDINE